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Obstructive sleep apnea syndrome (OSAS) is a sleep-related breathing disorder
that aﬀects both women and men. The aim of this study was to characterize and
investigate the diﬀerences in terms of anxiety, depression, illness perception, and
quality of life between female and male OSAS patients from a total of 111
patients (33 women and 78 men) who were recently diagnosed with OSAS in an
outpatient clinic of a University Hospital in Portugal. They underwent a
standardized protocol that included evaluation to assess of psychological
morbidity (anxiety and depression – Hospital Anxiety and Depression Scale),
illness representations (Brief Illness Perception Questionnaire), and quality of life
(Sleep Apnea Quality of Life Index). The most signiﬁcant diﬀerences between
female and male OSAS patients result of apnea/hypopnea index (AHI), after
controlling for body mass index (p 5 0.05); anxiety (p ¼ 0.000) and depression
(p 5 0.005); consequences (p 5 0.005), identity (p ¼ 0.000), coherence
(p 5 0.01), and emotional representation (p 5 0.005) of OSAS; and for daily
functioning (p ¼ 0.000), emotional (p ¼ 0.001), and symptoms (p 5 0.05)
domains of quality of life. Data suggest that women revealed more psychological
morbidity associated with OSAS. Therefore, it seems extremely important to look
at women as potential patients for sleep apnea and avoid looking up for a pattern
of symptoms that rely on men as a norm to which women are compared.
Keywords: obstructive sleep apnea syndrome; anxiety; depression; illness
representations; quality of life
Introduction
Obstructive sleep apnea syndrome (OSAS) is a highly widespread sleep-related
breathing disorder in adults. The estimated prevalence in western countries has a
range of about 2–4% for men and 1–2% for women (Young, Evans, Lin, & Patla,
1997; Young, Peppard, & Gottlieb, 2002). The male-to-female ratio is estimated
between 3:1 and 5:1 in the general population and at 8:1 to 10:1 in some clinical
populations (Young et al., 1993). In order to evaluate the development of OSAS, it is
important to notice that what follows the occurrence of an apnea is an arousal that
aﬀects patient’s normal breath (American Academy Sleep Medicine Task Force
[AASM], 1999). Inevitably, the quality of sleep is impaired. More precisely, OSAS is
a respiratory problem characterized by recurrent episodes of partial and/or complete
*Corresponding author. Email: rutesampaio@iol.pt
Psychology, Health & Medicine
2011, 1–14, iFirst Article
ISSN 1354-8506 print/ISSN 1465-3966 online
 2011 Taylor & Francis
DOI: 10.1080/13548506.2011.579986
http://www.informaworld.com
D
ow
nl
oa
de
d 
by
 [b
-o
n: 
Bi
bli
ote
ca
 do
 co
nh
ec
im
en
to 
on
lin
e U
M
inh
o]
 at
 03
:53
 03
 N
ov
em
be
r 2
01
1 
upper airway obstruction resulting in hypopnea or apnea, deﬁned as a 10 s minimum
interval, that are signiﬁcant when the number of events are superior than ﬁve per
hour. The apnea/hypopnea index (AHI) describes the severity of OSAS according to
standard criteria as follows: mild as an AHI between 5 and 15 events/h; moderate as
an AHI between 15 and 30 events/h; and severe as an AHI superior a 30 events/h
(AASM Task Force, 1999). The distribution of AHI is continuous and it increases
with age (Young et al., 2002). Since it is a prevalent sleep disorder, Tarasiuk,
Greenberg-Dotan, Brin, Tal, and Reuveni (2005) stated that OSAS patients are
frequent users of health care services in terms of hospitalization, outpatients clinic
visits, and medication use. Patients usually develop two disabling symptoms:
excessive daytime sleepiness and loud snoring witnessed by the bed partner. Other
symptoms are also important to support the diagnosis of OSAS, such as nocturnal
choking or gasping, nocturia, impotence, fatigue, morning headaches, and memory
impairment (McNicholas, 2008). OSAS has been also associated with a decrease of
work productivity (Mulgrew et al., 2007), social problems (Glebocka, Kossowska, &
Bednarek, 2006), reduced participation and enjoyment in everyday activities
(Engleman & Douglas, 2004), and marital problems (Parish & Lynq 2003).
Moreover, other important consequences of sleepiness are car and work accidents
(Findley & Suratt, 2001; Krieger et al., 1997; McArdle et al., 1999; Tera´n-Santos
et al., 1999). All these symptoms and their consequences have impact on the
biological, social, and psychological domains of the patient.
A clear relationship between OSAS and hypertension has been consistently
demonstrated, and OSAS increases the likelihood of this disorder (Grotz et al., 2006;
Yaggi et al., 2005). Undiagnosed OSAS is one of the main reasons for the
development of hypertension and accepted as one of its main causes by the 7th Joint
National Committes Report (Dursunoglu et al., 2006). OSAS, hypertension, and
obesity coexist and share most of the pathogenesis and cardiovascular consequences
(Wolf, Lewicka, & Nartiewicz 2007). It is well known that obesity is a major risk
factor for OSAS (Young et al., 1993), and in the Wisconsin Sleep Cohort Study,
OSAS females had a greater body mass index (BMI) than OSAS males (Young,
Hutton, Finn, Badr, & Patla, 1996).
Most studies measuring quality of life with SF-36 show aspects of quality of life
markedly impaired in OSAS (Ambrosio, Bowman, & Mohsenin, 1999; Gonc¸alves,
Paiva, Ramos, & Guilleminault, 2004; Jenkinson, Stradling, & Petersen, 1997; Smith
& Shneerson, 1995). This holds true when using the Calgary Sleep Apnea Quality of
Life Index (SAQLI) that assesses speciﬁcally quality of life in sleep apnea patients
(Flemons & Reimer, 2002). In a systematic review of quality of life, in obstructive
sleep apnea, conducted by Moyer, Sonnad, Garetz, Helman, and Chervin (2001), the
impairment in quality of life is well documented and the authors suggest the SAQLI
to be a potentially useful instrument.
The impairment of cognitive performance and mood are two of the main
consequences of nocturnal hypoxemia or severe sleepiness (Engleman & Douglas,
2004). An European study of 18,980 subjects, including Portugal, concluded that
17.6% of subjects with a breathing-related sleep disorder also presented a major
depressive disorder, after controlling for obesity and hypertension (Ohayon, 2003). In a
review addressing the practical clinical aspects of the complex relationship between
psychiatric disorders and sleep, Sateia (2009) states that women demonstrate more
depressive symptoms than men, although apnea severity did not diﬀer between groups.
Also, depression explained about 25% of the variance for fatigue, whereas OSAS
2 R. Sampaio et al.
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severity explained only 13% (Bardwell, Ancoli-Israel, & Dimsdale, 2007 cited by Sateia,
2009). Another review conducted by Schro¨der and O’Hara (2005) describes the
existence of a complex relationship between depression and OSAS in terms of clinical
presentation and varies widely depending on age, gender, AHI, and general
demographic and health characteristics of the patients under investigation. The
authors advised for the need of taking into account the diﬀerent subtypes of mood
disorder as well as the causal relationship and mechanisms between depression and
OSAS. OSAS patients also have high values of anxiety (16.7% in a American survey of
4060 subjects) (Glebocka et al., 2006), deﬁned as tension and irritability, as a direct
consequence of sleep impairment (Bardwell, Berry, Ancoli-Israel, & Dimsdale, 1999).
Illness perception is a very important construct introduced by Leventhal, Meyer, and
Nerenz (1984) referring to how individuals tend to construct their own illness
representation and its inﬂuence on health behavior, namely therapeutic adherence
(Ogden, 2004). When symptoms of OSAS are visible or cause pain, patients give them
more attention. This selective attention to symptoms has serious consequences when
the symptoms, although serious, are still scarcely perceptible, as pointed by Knauper
(2001). The perception and interpretation of symptoms arise from the relationship
between external and internal stimuli and from individuals’ beliefs. Awareness of
symptoms is strongly aﬀected by psychological factors and when diagnosed with a
disease, the individual develops beliefs regarding the condition that inﬂuence the
decision concerning the best strategies to manage the disease (Petrie & Pennebaker,
2004). Psychological states such as anxiety and depression make people more aware of
physical problems (Petrie & Pennebaker, 2004) and patients with depressed mood are
more pessimistic about the action they can take in relation to symptoms, than patients
without depressive symptoms (Knauper, 2001). In the present moment, we are not
aware of any studies that have assessed illness perception in OSAS.
The aim of the present study was to assess clinical, sociodemographic, and
psychological such as anxiety, depression, illness perception, and quality of life in
female and male patients from a cohort of patients who were recently diagnosed with
OSAS in an outpatient clinic of a University Hospital. According to literature, we
expected a relationship among depression, anxiety, less quality of life, more
threatening illness representations, and sleepiness on both female and male patients.
It was also hypothesized that when compared with male patients, female patients
would report signiﬁcantly more anxiety, depression, less quality of life, and more
threatening illness representations.
Material and methods
Participants
During a six month period, consecutive patients, presenting to the Sleep Disordered
Breathing Clinic of a University Hospital with OSAS diagnosis with CPAP
treatment indication, underwent a standardized protocol that included general clinic
evaluation by the sleep specialist, home sleep study, and a psychological evaluation
that included psychological morbidity, illness perceptions, and quality of life. None
of the participants had a psychiatric disorder or other sleep disorders.
The study was approved by S. John’s Hospital research ethics committee, and
written informed consent was obtained from all participants before participation in
the study.
Psychology, Health & Medicine 3
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Disease assessment – home sleep study
An overnight sleep study was performed using a ﬁve-channel recording device (Sleep
Screen, ViasysTM Healthcare) that produces a computerized recording of variations
in oronasal airﬂow (measured by nasal cannula), body position, wrist actimetry,
pulse rate, and arterial oxygen saturation (measured by ﬁnger pulse oximetry). The
device estimates the total sleep time, and it automatically calculates the number of
apneas plus hypopneas per hour of estimated sleep time. Sleep technicians carried
out a manual analysis of the recordings, by counting apnea (episodes of 20% of
previous airﬂow with at least 10 s of duration) and hypopnea episodes (episodes
showing 20–50% of the previous airﬂow, with at least 10 s of duration together with
a 4% dip in oxygen saturation and/or an arousal), dividing the total number of these
episodes by the sleep time in hours, obtaining a manual respiratory disturbance
index according to established criteria (AASM Task Force, 1999).
Psychological assessment
All the patients diagnosed with OSAS completed four self-report measures after a
signed informal consent. For this study, four questionnaires were used: Hospital
Anxiety and Depression Scale (HADS) (Zigmond, A. & Snaith, 1983); Brief Illness
Perception Questionnaire (IPQ-B) (Broadbenta, Petrie, Maina, & Weinman, 2006);
SAQLI (Flemons & Reimer, 2002); and Epworth sleepiness scale (ESS; Johns, 1991).
All instruments were used in their Portuguese adapted versions.
Hospital Anxiety and Depression Scale (adaptation by McIntyre, Pereira, Soares,
Gouveis, & Silva, 1999) consists of two subscales – one measuring anxiety and the
other measuring depression – with seven items each, using a four point (0–3) response
category. Hence, scores on both scales range between 0 and 21. On both subscales, a
score of 57 is interpreted as normal; between 8 and 10 borderline; and 411
corresponding to a clinical diagnosis of anxiety and depression (Snaith & Zigmond,
1983). According to the authors, a cut-oﬀ threshold of 11 for depression or anxiety,
means clinical depression or anxiety, respectively.
Illness Perception Questionnaire-Brief ((Broadbent, Petrie, Main, & Weinman,
2006) adapted version of Figueiras et al., 2009) assesses illness perceptions using a
10-point likert scale, in a total of eight items. Five of the items assess cognitive illness
representations: consequences (1), timeline (2), personal control (3), treatment
control (4), and identity (5). Two of the items assess emotional representations:
concern (6) and emotions (8). One item assesses illness comprehensibility (7). Causal
representation is answered in an open-ended response. High scores (total result)
reveal a more threatening perception of the illness.
Sleepiness Apnea Quality of Life Index ((Flemons & Reimer, 1998) Portuguese
version research of Sampaio, Pereira, & Winck 2008)) is a questionnaire, using a
seven-point likert scale, designed as a disease-speciﬁc quality of life measure of
people with OSAS. It has ﬁve domains, with the number of items following in
parentheses: daily functioning (11); social interactions (13); emotional functioning
(11); symptoms (5); and treatment-related symptoms (5) [not in use in this ﬁrst
evaluation moment]. The low end of scale reveals the least impairment (1–2), and the
high end of scale reveals the greatest impairment (6–7).
Epworth Sleepiness Scale (adapted version from Center of Studies and Research
in Health from Coimbra University) is a self-report questionnaire that evaluates the
4 R. Sampaio et al.
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probability of falling asleep in eight situations while ‘‘inactive in a public place,’’ ‘‘at
work,’’ and ‘‘in a moving vehicle passenger or driver’’ (Johns, 1991). Subjects are
asked to rate on a scale of 0–3 how likely they would fall asleep, and the global score
ranges from 0 to 24. A total score higher than 17 suggests a severe daytime sleepiness
and between 11 and 17 suggests a moderate daytime sleepiness (Johns, 1991).
Data analysis
To test diﬀerences between female and male patients on psychological and clinical
variables, the multivariate analysis of variance (MANOVA) test was used and Qui-
Square for daily somnolence were also employed. To test the relationship among all
psychological variables for male and female patients, partial Pearson correlations
were used for controlling illness severity.
Results
Sociodemographic characterization and clinic variables in female
and male patients
The study included 111 patients, 78 men and 33 women. The mean age was 54.2
(SD ¼ 7.36) for women and 52.77 (SD ¼ 9.82) for men. The majority of the patients
were married. Of these, 68.7% were females and 84.6% were males. In total, 66.7%
of female patients had less or four years of education, which was signiﬁcantly
diﬀerent (w2(1) df ¼ 6.74, p 5 0.05) from male patients (39.7%). Both female and
male patients lived in the majority of cases, in an urban area, 68.2% for women and
69.2% for men. Almost half (45.5%) of female patients and 61.5% of male patients
were employed. The majority of patients were obese. Female patients had a mean
BMI of 36.45 (SD ¼ 6.91) and male patients 33.17 (5.98).
AHI was about 39.33 (SD ¼ 19.8) for women and 46.18 (SD ¼ 16.92) for men
and signiﬁcantly diﬀerent between female and male patients, and controlling for
BMI (F(1, 108) ¼ 6.79, p 5 0.01). In total, 51.3% of male patients and 18% of
female patients had hypertension. In all, 30% of female patients and 21% of male
patients evaluate their somnolence as severe (Table 1).
Relationship among BMI, sleepiness, anxiety, depression, illness representation, quality
of life in female and male OSAS patients controlling for OSAS severity
In female OSAS patients, anxiety and depression (r ¼ 0.469, p 5 0.01) and anxiety
and illness representations (r ¼ 0.425, p 5 0.5) were positively correlated. Depres-
sion was also positively correlated with illness representations (r ¼ 0.493, p 5 0.05;
Table 2). Quality of life was negatively correlated with anxiety (r ¼ 70.358,
p 5 0.05), depression (r ¼ 70.588, p 5 0.01), and with illness representation
(r ¼ 70.500, p 5 0.01) (Table 2). Daily somnolence was negatively correlated with
quality of life (r ¼ 70.369, p 5 0.05) (Table 2).
In male OSAS patients, the results for correlations were in the same direction as
female patients for all psychological variables, controlling for OSAS severity.
Anxiety and depression (r ¼ 0.682, p 5 0.01), anxiety and illness representation
(r ¼ 0.589, p 5 0.01), and depression and illness representation (r ¼ 0.410,
p 5 0.01) were highly correlated (Table 3). Finally, quality of life was negatively
correlated with depression (r ¼ 70.610, p 5 0.01), anxiety (r ¼ 70.688, p 5 0.01),
Psychology, Health & Medicine 5
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illness representation (r ¼ 70.602, p 5 0.01), and also with daily somnolence
(r ¼ 70.433, p 5 0.01) (Table 3). All Pearson correlation coeﬃcients were similar,
indicating that the all psychological variables indexes are comparable.
Diﬀerences between female and male patients on anxiety, depression, quality of life,
and daily somnolence
The results for MANOVA tests (Table 4) revealed signiﬁcant statistics diﬀerences
between female and male OSAS patients in all psychological variables (Lambda de
Wilks ¼ 0.81; F(6, 104) ¼ 4.05, p 5 0.001). Female patients had signiﬁcant levels of
anxiety (F ¼ 14.37, p ¼ 0.000) and depression (F ¼ 11.54, p 5 0.001) symptoms
when compared with male patients. Considering each domain of quality of life, a
Table 2. Relationships among clinical variables (AHI, BMI, and sleepiness) and
psychological variables (anxiety, depression, illness representation, and quality of life) for
female patients controlling for OSAS severity.
ESS Anxiety Depression IPQ SAQLI
BMI
Sleepiness 70.369*
Anxiety 0.469** 0.425* 70.358*
Depression 0.469** 0.493** 70.588**
Illness representations 0.425* 0.493** 70.500**
Quality life 70.369* 70.358* 70.588** 70.500**
Note: **p 5 0.01, *p 5 0.05.
Table 1. Sociodemographic and clinical variables on female and male patients with OSAS.
Female (n ¼ 33) Male (n ¼ 78)
Variables n (%) M (SD) n (%) M (SD)
Marital status 23 (69.7%)
married
66 (84.6%)
married
Literacy 22 (66.7%)
 4 years
education
31 (39.7%)
 4 years
education
Residence
Rural 11 (33.3%) 24 (30.8%)
Urban 22 (66.7%) 54 (69.2%)
Professional status
Employed 15 (45.5%) 48 (61.5%)
Retired 10 (30.3%) 18 (23.1%)
Unemployed 6 (18.2%) 8 (10.3%)
Age 54.2 (7.36) 52.8 (9.82)
BMI (kg/m2) 36.45 (6.91) 33.17(5.98)
AHI (events p/h)
(BMI as a
covariate)
39.33 (19.8) 46.18(16.92)
Hypertension 18 (54.5) 40 (51.3)
Sleepiness NS-9 (27) NS-26 (33)
MS-14 (43) MS-36 (46)
SS-10 (30) SS-16 (21)
6 R. Sampaio et al.
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higher impairment in symptoms for both genders was found (M ¼ 2.39 for female
and M ¼ 3.49 for male), and this diﬀerence was signiﬁcant (F ¼ 6.81, p 5 0.010).
The emotional domain was moderately impaired in female patients (M ¼ 3.53) but
not in male patients (M ¼ 4.44), and this diﬀerence was signiﬁcant (F ¼ 11.05,
p 5 0.001). The domains of daily functioning and social interactions were not
impaired for both genders despite existing signiﬁcant diﬀerences between female and
male patients on daily functioning (F ¼ 15.13, p ¼ 0.000) perceived as moderately
impaired (M ¼ 4.04) by female patients compared with male patients (M ¼ 5.24).
There are no diﬀerences between female and male patients on daily somnolence
(w2(2) df ¼ 1.29, ns) (Figure 1).
Finally, signiﬁcant diﬀerences between female and male OSAS patients were
found on consequences (t(109) ¼ 3.42, p 5 0.01), identity (t(109) ¼ 4.12,
p 5 0.01), coherence (t(109) ¼ 72.75, p 5 0.01), and emotional representations
(t(109) ¼ 3.06, p 5 0.01). Female patients tend to perceive OSAS as more
Table 3. Relationships among clinical (AHI, BMI, and sleepiness) and psychological
variables (anxiety, depression, illness representations, and quality of life) for male patients
controlling for OSAS severity.
Sleepiness Anxiety Depression IPQ SAQLI
Body mass index
Sleepiness 0.411** 70.433
Anxiety 0.682** 0.589** 70.688**
Depression 0.682** 0.410** 70.610**
Illness representations 0.411** 0.589** 0.410** 70.602**
Quality life 70.433** 70.688** 70.610** 70.602**
Note: **p 5 0.01, *p 5 0.05.
Table 4. Diﬀerences between female and male patients with Sleep Apnea Obstructive
Syndrome on Anxiety, Depression, Daily Functioning, Social Interactions, Emotional
Functioning and Symptoms.
Female (n ¼ 33), Male (n ¼ 78), MANOVA,
Variables M (SD) M (SD) F p
Anxiety 11.61 (4.84) 8.10 (4.28) 14.37 0.000
Depression 8.27 (4.47) 5.58 (3.51) 11.54 0.001
Quality of life
Daily Functioning 4.04 (1.48) 5.24 (1.48) 15.13 0.000
Social Interactions 4.67(1.22) 5.09 (1.27) 2.62 0.108
Emotional Functioning 3.53 (1.28) 4.44 (1.35) 11.05 0.001
Symptoms 2.39 (1.84) 3.49 (2.09) 6.81 0.010
Illness representations
Consequences 6.88 (2.96) 4.54 (3.43) 3.42 0.001
Timeline 6.03 (2.88) 5.28 (3.19) 1.61 0.248
Personal control 5.00 (3.29) 5.03 (3.08) 70.039 0.969
Treatment control 8.73 (2.04) 8.90 (1.87) 70.427 0.670
Identity 7.58 (2.68) 4.86 (3.36) 4.12 0.000
Concern 7.85 (3.15) 7.77 (2.98) 0.126 0.900
Coherence 5.79 (3.18) 7.49 (2.88) 72.75 0.007
Emotional representation 7.88 (3.24) 5.72 (3.47) 3.06 0.003
Psychology, Health & Medicine 7
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threatening in all domains of illness representations compared with male patients
(Figure 2).
Discussion
As it was described by Young et al. (1993), it is well known that OSAS is more
common in men than in women. The reason for the apparent discrepancy between
genders in clinical prevalence of OSAS is not clear (Dietlind et al., 2007). Some
possible explanations have been suggested for Young et al. (1996), namely the
Figure 2. Mean results of illness representations for female and male patients.
Figure 1. Mean results of quality of life scales for female and male patients.
8 R. Sampaio et al.
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diﬀerence in clinical presentation, tolerance of symptoms, amount of medical
services, bias created by the expectation of the attending physician of a higher
prevalence of men with OSAS. The ﬁrst diﬀerence to notice is the highest level of
education in male patients, which represents the general tendency of Portuguese
population (Instituto Nacional de Estatı´stica (INE), I.P., 2010). Some studies
pointed out that more women than men have BMI  30 (Lin, Davidson, & Ancoli-
Israel, 2008; Valipour et al., 2007). In our study, the severity of OSAS is higher in
male patients, and this result is in accordance with the literature (Wahner-Roedler
et al., 2007; Yukawa et al., 2009). We also found a positive relationship between
severity of OSAS and BMI, and this result is in accordance with the literature
(Dursunoglu, Ozkurt, & Sarikaya, 2009; Wahner-Roedler et al., 2007).
No diﬀerences were found (Lin et al., 2008; Ye, Pien, & Weaver, 2009). between
female and male patients on daily somnolence, and this result is also in accordance
with the literature. Both male and female evaluated their somnolence in a moderate
level, although the majority has a high AHI. It is well accepted that high somnolence
is not a diagnosis of a particular sleep disorder (Johns, 1991). It is possible that the
threshold at which women or men feel daytime sleepiness is lower and misunder-
stood as is fatigue. According to Dursunoglu and Dursunoglu (2007), Dursunoglu
et al. (2009) and Hahn and Staats (2004), women present frequently ‘‘atypical
symptoms,’’ which generate uncertainty, e.g., fatigue, morning headaches, insomnia,
depression, and great use of sedatives. The severity of sleep apnea is important and is
related with all of the psychological variables measured, except for BMI recognized
as an important variable for the diagnosis of sleep apnea. Therefore, it might be
important when establishing the diagnosis of OSAS understand psychological
morbidity, illness representations, and quality of life that seem to be impaired as a
result of the disease, for both female and male patients. Additionally, clinicians need
to be more vigilant regarding the presence of other psychological symptoms in their
patients, mostly in female patients. In fact, as expected, a relationship between
anxiety, depression, illness representations, and quality of life for both female and
male patients was found, i.e., more anxiety and depression are related with less
quality of life. In the same way, the more the disease is perceived as threatening, the
lower is the quality of life. We also found a relationship between sleepiness and
impaired quality of life for female OSAS patients. In male patients, a relationship
was found between sleepiness, illness representations, and impaired quality of life.
Perhaps when the patients perceive the main symptom of OSA that is somnolence,
they represent their illness as more threatening and perceive their quality of life more
impaired. BMI in males was also related to OSAS severity, which may act as a main
factor for the increased prevalence of OSAS in male patients.
Depression has been well documented in various studies that underscore the
existence of a complex relationship between depression and OSAS (Schro¨der &
O’Hara, 2005). In a review conducted by Harris, Glozier, Ratnavadivel, and
Grunstein (2009), despite a plethora of studies, there is no clear evidence of the role
of OSAS in depression. In a study conducted by Cross et al. (2008), designed to
determine whether brain alterations in OSAS bear relationships to depressive
symptoms, the authors found depressive symptoms independent of the sleep
disorder. Previous studies found that women had higher depression scores when
compared with men (Dursunoglu et al., 2009; Pillar & Lavie, 1998). In the present
study, female patients showed borderline values for clinical depression, and male
patients showed an absence of depression. Some experts argue that depression
Psychology, Health & Medicine 9
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measures are magniﬁed by the predominantly physical symptoms that are present in
depression. As a result, depressive symptoms may be an emotional reaction to a
chronic medical illness diagnosis (Means et al., 2003). In our study, depressive
symptoms were measured at the same moment as the diagnosis was provided, which
may explain an absence of depression for male patients as a reaction to the diagnosis.
Also the majority of male patients address for help due to their bed partners
awareness of their apneic events (Dursunoglu et al., 2009). Women tend to report
frequently a number of unrelated sleep symptoms that can promote misdiagnosis of
OSAS (Jordan & McEvory, 2003). In fact, depression and insomnia are intertwined
and are both more common in females (Shepertycky, Banno, & Kryger, 2005). So, it
is necessary to measure depressive symptoms in the ﬁrst attendance in hospital
settings and be sensitive to their importance on OSA diagnosis in female patients.
Reports of anxiety in the context of OSAS are less common than depression, and
it seems that this relationship is still poorly understood (Kjelsberg, Ruud, & Stavem,
2005). In the present study, female patients have signiﬁcantly higher anxiety
symptoms compared with male patients, whose values are below clinical signiﬁcance.
As a whole, these anxiety symptoms are highly correlated with depression and illness
perception. These data are conﬁrmation of the Leventhal et al.’s self-regulation
model (Moss-Morris et al., 2002) that postulates that cognitive illness perceptions
are assimilated in parallel to emotional illness perceptions. As a result, as more
illness symptoms are identiﬁed, the higher is the emotional response, like anxiety,
depression and more impaired is the emotional functioning in quality of life,
presented in female patients. This may also be related with a higher concern, with the
illness, found in female patients. Furthermore, female patients tended to perceive
OSAS as more threatening than male patients, revealed by the higher levels perceived
in sleep apnea consequences, symptoms, emotional impairment, and lower perceived
comprehensibility of illness. It is important to notice that we found only one study
that used an interview focus on perceived eﬀects and needs in general to comprehend
how unthreatening patients with OSAS perceived their sleep situation and how the
syndrome aﬀected their life (Brostrom et al., 2007). Our study is the ﬁrst that used a
validated instrument speciﬁed to appraise illness perception – the IPQ-b.
OSAS clearly aﬀects important domains of quality of life, which remain unexplored
in the sleep laboratory. Quality of life per se has been an aim of many studies, and it has
been measured mostly with generic illness measures (life SF-36) analyzing non-speciﬁc
quality of life aspects (Ambrosio et al., 1999; Gonc¸alves et al., 2004). Less attention has
been given to its particular impact in female and male patients. In a recent review, the
authors state that gender diﬀerences in the functional status of OSA patients, which is a
component of quality of life, have not been well investigated (Ye et al., 2009). In the
present study, we use an illness-speciﬁc scale (SAQLI) designed to assess the impact
OSAS on quality of life. We ﬁnd out a medium impact in quality of life (total) described
by female patients and a lower impact for male patients. In a report ascribed by Ye
et al. (2009) that used functional outcomes sleep questionnaire, women reported lower
perceived health status and poorer functional status measures compared with men.
Specifying the domains of the scale, the diﬀerences between female and male patients
were substantially, except for social interactions domain. Daily functioning domain is
higher impaired in female patients than in male patients. It can be hypothesize that due
to women being late diagnosed and received treatment later than men (Wahner-
Roedler et al., 2007), they felt impaired in their daily functioning. The higher level of
impairment was established in the symptoms domain for both genders, although for
10 R. Sampaio et al.
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female patients symptoms were signiﬁcant higher than in male patients. This is the
general tendency postulated in most studies that used SAQLI in OSAS patients
(Mador, Krauza, Pervez, Pierce, & Braun, 2005; Siccoli et al., 2008). Curiously, the
emotional domain was moderately impaired only in female patients, which is
signiﬁcantly diﬀerent than male patients. This outcome may indicate a higher concern
with sleep apnea by women and therefore an exacerbation of anxiety symptoms.
Moreover, this result conﬁrms the importance to look up at emotional response,
namely depressive and anxiety symptoms, as a distinctive aspect to be evaluated in
female OSAS patients. In this study, patients did not perceive the social interactions
domain as problematic. Similarly, as it was found in other studies, our patients, both
female and male, maintain a reasonable social functioning (Gonc¸alves et al., 2004).
Dursunoglu et al. (2009) pointed out the necessity to be aware of sleep apnea in women
and the importance of referring women for sleep studies when they complain of
symptoms associated with OSAS. Perhaps, the reality of undiagnosed women is
changing and what cohort study (Young et al., 1997) mentioned (more than 90%
women undiagnosed) is no longer true.
Limitations
Due to the prevalence of the OSAS, we had an unbalanced distribution in survey,
which represents the normal ratio between female and male OSAS patients. Another
limitation is the use of self-report measures.
Conclusion
The aim of our study was to understand how anxiety, depression, illness perception,
and quality of life diﬀer in female and male OSAS patients. Therefore, it seems
extremely important to look at women as potential patients for sleep apnea. The
investigation in this area emphasizes a pattern of symptoms well established that
distinguish women from men. In fact, research in this ﬁeld seems to rely on men as a
norm to which women are compared. In the same way, the idea of an health care
system ruled to gender is not new and is associated with multiple diseases, such
OSAS. So it would be important to highlight unique factors in female OSAS patients
to avoid inconsistent and sometimes false diagnosis of OSAS. For this purpose, it is
necessary to integrate a domain of knowledge capable of evaluating variables that
may have an impact on somatic complains. So it is extremely important to perceive
how female and male patients cognitively and emotionally perceive their illness and
be aware of the impact of these variables in coping with illness and adhering to its
preferential treatment – CPAP.
Future investigations need to integrate several domains of knowledge to assess
female and male patients as a distinct group of patients with speciﬁc needs and
support. So, for future it is necessary to be aware of the psychological impairment in
female OSAS patients and promote a multidisciplinary intervention capable to treat
all important aspects of an illness with so many consequences.
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